Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.1K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.1K
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

16.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
Genetic Lingo01:11

Genetic Lingo

107.1K
Overview
107.1K
Genetic Variation01:25

Genetic Variation

878
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
878
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

854
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
854

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.

The Lancet. Neurology·2026
Same author

Generation of Blood Vascular Endothelial-Neural 3D Organoids by Serial Induction of Differentiation on Human iPSC-Derived Embryoid Bodies.

Cells·2026
Same author

Long-read sequencing maps transposable element variation and its regulatory and epigenetic effects in the human brain.

bioRxiv : the preprint server for biology·2026
Same author

iPSC Neurodegenerative Disease Initiative isogenic CAG repeat iPSC line for Huntington's disease.

bioRxiv : the preprint server for biology·2026
Same author

R1398 is the GTP-γ-phosphate sensor that drives the ROC G-domain switching mechanism unique to Parkinson's disease-associated LRRK2.

Research square·2026
Same author

<i>LRRK2</i> in Focus: A Global Browser Linking Genetic Diversity to Functional Effects.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Oct 19, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.1K

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk.

Julie Lake1, Xylena Reed1, Rebekah G Langston1

  • 1Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|September 20, 2021
PubMed
Summary

The leucine-rich repeat kinase 2 (LRRK2) gene

Keywords:
LRRK2Parkinson's diseaseassociationgenetics

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.5K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.7K

Related Experiment Videos

Last Updated: Oct 19, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.1K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.5K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.7K

Area of Science:

  • Genetics
  • Neuroscience
  • Epidemiology

Background:

  • The leucine-rich repeat kinase 2 (LRRK2) gene is implicated in Parkinson's disease (PD) risk.
  • Both rare missense variants (e.g., p.G2019S) and common noncoding variants (e.g., rs76904798) are associated with PD.
  • Understanding the independent contributions of these variants is crucial for PD research.

Purpose of the Study:

  • To determine if the LRRK2 GWAS signal (rs76904798) is independently associated with PD risk, separate from LRRK2 coding variation.
  • To investigate if linkage disequilibrium explains the association of LRRK2 coding variants with PD.
  • To clarify the role of LRRK2 coding variation in PD etiology.

Main Methods:

  • A large meta-analysis of imputed genotypes from over 200,000 individuals (patients and controls) of European ancestry was performed.
  • Exclusion criteria were applied to carriers of specific LRRK2 variants (p.G2019S, rs76904798, rare coding variants) to assess independence.
  • Co-inheritance patterns of LRRK2 coding variants with p.G2019S and rs76904798 were investigated.

Main Results:

  • The LRRK2 variant rs76904798 remained significantly associated with PD risk even after excluding carriers of rare LRRK2 coding variants.
  • Specific LRRK2 variants (p.R1514Q and p.N2081D) showed frequent co-inheritance with rs76904798.
  • The allele distribution of p.S1647T was significantly altered in PD patients after accounting for rs76904798.

Conclusions:

  • LRRK2 coding variants previously linked to PD do not appear to drive the 5' noncoding GWAS signal.
  • The findings do not rule out an independent association of certain haplotypes (p.N551K-p.R1398H, p.M1646T) with altered PD risk.
  • This study provides insights into the complex genetic architecture of LRRK2 in Parkinson's disease.